Statins and non‐alcoholic fatty liver disease [PDF]
Liver International, 2019 Dear Editor, In April 9 issue, van den Berg et al1 report interesting results on the indication for lipid‐lowering treatment in a large cohort with suspected non‐alcoholic fatty liver disease (NAFLD) within the population‐based Lifelines Cohort Study.
Angelico F +3 more
openaire +4 more sources
Non-alcoholic fatty liver disease [PDF]
Medicine, 2015 A 58-year-old man was seen by his general practitioner; after a routine health check, he demonstrated elevated liver biochemistry, with an alanine aminotransferase (ALT) value of 45 IU/L. He had recently been diagnosed with hypertension with a BP of 162/101 mmHg and type 2 diabetes mellitus (T2DM) with a glycosylated haemoglobin (HbA1c) of 69 mmol/mol (
Jeremy Cobbold, Michael Pavlides
openaire +6 more sources
The association of vitamin D deficiency with non-alcoholic fatty liver disease [PDF]
, 2014 OBJECTIVE: Vitamin D deficiency has been related to diabetes, hypertension, hyperlipidemia and peripheral vascular disease. In this study, we aimed to investigate the role of vitamin D status in non-alcoholic fatty liver disease.
A?ladio?lu, Kadir +13 more
core +9 more sources
Machine Learning Algorithms Based Non Alcoholic Fatty Liver Disease Prediction [PDF]
, 2023 The early stage liver diseases prediction is an important health related research and using this kind of research easily can predict the diseases and take the remedies.
Bindu Bhargavi Munukuntla +1 more
core +1 more source
Concept of Fatty liver and its management in Ayurveda [PDF]
, 2021 Fatty liver disease is a most common liver disease affecting a wide range of population worldwide. It is caused due to excessive fat accumulation in liver cells resulting in inflammation in liver.
Behere (Saner), Punam +1 more
core +2 more sources
Bridging the diagnostic gap: liver function tests and IL-6 as potential early predictors of non-alcoholic fatty liver disease in psoriasis [PDF]
, 2023 Background: Psoriasis goes beyond skin, intertwining with body systems, notably connecting to nonalcoholic fatty liver disease (NAFLD). This study aims to explore the predictive potential: liver function tests and IL-6 as early markers for non-alcoholic ...
Adbullah, Tadamun +5 more
core +2 more sources
Impact of COVID-19 lockdown on non-alcoholic fatty liver disease and insulin resistance in adults: a before and after pandemic lockdown longitudinal study [PDF]
, 2022 Background: Non-alcoholic fatty liver disease is a chronic disease caused by the accumulation of fat in the liver related to overweight and obesity, insulin resistance, hyperglycemia, and high levels of triglycerides and leads to an increased ...
Altisench Jané, Bárbar +5 more
core +1 more source
To identify and examine the different causes of liver disease in Sri Lanka [PDF]
, 2017 © 2017 The Authors. Published by International Journal of Science and Research. This is an open access article available under a Creative Commons licence.
Aslam, Fahim, Kulasena, Hashan
core +1 more source
Hypoxia and Non-alcoholic Fatty Liver Disease [PDF]
Frontiers in Medicine, 2020 Non-alcoholic fatty liver disease (NAFLD) is currently the most common chronic liver disease worldwide and comprises varied grades of intrahepatic lipid accumulation, inflammation, ballooning, and fibrosis; the most severe cases result in cirrhosis and liver failure.
Carmelo García-Monzón +5 more
openaire +5 more sources
Non-alcoholic fatty liver disease and associated factors among type 2 diabetic patients in southwest Ethiopia [PDF]
, 2018 Background: Non-alcoholic Fatty Liver Disease (NAFLD) among type 2 diabetic patients is completely ignored in developing regions like Africa paving the way for public health and economic burden in the region.
Bobasa, Eshetu Mulisa +4 more
core +2 more sources